Recombinant hCG versus dual triggering for final oocyte maturation in ICSI cycles among poor responders with endometriosis
Abstract This double-blind randomized clinical trial compared recombinant human chorionic gonadotropin (rhCG) alone with dual triggering (gonadotropin-releasing hormone agonist plus rhCG) for final oocyte maturation in women with endometriosis and poor ovarian response (Bologna criteria) undergoing intracytoplasmic spe...